Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph W Kim

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Oncoimmunology|December 14, 2020
A Phase 1b Study Evaluating the Safety, Tolerability, and Immunogenicity of CMB305, a Lentiviral-Based Prime-Boost Vaccine Regimen, in Patients with Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1Neeta Somaiah, Sant P Chawla, Matthew S Block, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 18, 2022
Randomized Trial of Olaparib With or Without Cediranib for Metastatic Castration-Resistant Prostate Cancer: The Results From National Cancer Institute 9984Joseph W Kim, Rana R McKay, Marc R Radke, et al.
BJU International|September 24, 2020
Cabozantinib plus docetaxel and prednisone in metastatic castration-resistant prostate cancerRavi A Madan, Fatima H Karzai, Munjid Al Harthy, et al.
BMC Public Health|September 17, 2024
Adaptation of the socioecological model to address disparities in engagement of Black men in prostate cancer genetic testingAmy E Leader, Timothy R Rebbeck, William K Oh, et al.
The New England Journal of Medicine|September 16, 2024
Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial CarcinomaAndrea B Apolo, Karla V Ballman, Guru Sonpavde, et al.
Journal of the National Cancer Institute|August 11, 2023
Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary TumorsTalal El Zarif, Amin H Nassar, Gregory R Pond, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Oncoimmunology|December 14, 2020
A Phase 1b Study Evaluating the Safety, Tolerability, and Immunogenicity of CMB305, a Lentiviral-Based Prime-Boost Vaccine Regimen, in Patients with Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1Neeta Somaiah, Sant P Chawla, Matthew S Block, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 18, 2022
Randomized Trial of Olaparib With or Without Cediranib for Metastatic Castration-Resistant Prostate Cancer: The Results From National Cancer Institute 9984Joseph W Kim, Rana R McKay, Marc R Radke, et al.
BJU International|September 24, 2020
Cabozantinib plus docetaxel and prednisone in metastatic castration-resistant prostate cancerRavi A Madan, Fatima H Karzai, Munjid Al Harthy, et al.
BMC Public Health|September 17, 2024
Adaptation of the socioecological model to address disparities in engagement of Black men in prostate cancer genetic testingAmy E Leader, Timothy R Rebbeck, William K Oh, et al.
The New England Journal of Medicine|September 16, 2024
Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial CarcinomaAndrea B Apolo, Karla V Ballman, Guru Sonpavde, et al.
Journal of the National Cancer Institute|August 11, 2023
Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary TumorsTalal El Zarif, Amin H Nassar, Gregory R Pond, et al.
Pageof 4